ACADM and nonpapillary renal cell carcinoma: In addition, based on TCGA data, significantly longer overall survival times were shown in patients with higher expression of these three hub genes, indicating that EHHADH, ACADM and AGXT2 were prognostic biomarkers for ccRCC (Figures 4B, D, F).